Skip to main content

Lipocine Inc. (LPCN)

NASDAQ: LPCN · IEX Real-Time Price · USD
1.06 -0.03 (-2.75%)
Oct 22, 2021 4:00 PM EDT - Market closed
Market Cap93.77M
Revenue (ttm)n/a
Net Income (ttm)-19.00M
Shares Out88.29M
EPS (ttm)-0.25
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume354,556
Open1.08
Previous Close1.09
Day's Range1.05 - 1.09
52-Week Range0.98 - 2.42
Beta0.50
AnalystsBuy
Price Target4.75 (+348.1%)
Est. Earnings DateNov 9, 2021

About LPCN

Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of metabolic and endocrine disorders. Its primary development programs are based on oral delivery solutions for poorly bioavailable drugs. The company has a portfolio of product candidates designed to produce pharmacokinetic characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailabili...

IndustryPharmaceuticals
CEOMahesh Patel
Employees13
Stock ExchangeNASDAQ
Ticker SymbolLPCN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for Lipocine stock is "Buy." The 12-month stock price forecast is 4.75, which is an increase of 348.11% from the latest price.

Price Target
$4.75
(348.11% upside)
Analyst Consensus: Buy

News

Lipocine, Antares Ink Licensing Pact For Testosterone Replacement Therapy In US

Lipocine Inc (NASDAQ: LPCN) has entered into an exclusive licensing agreement with Antares Pharma Inc (NASDAQ: ATRS) to commercialize Tlando in the U.S.  Tlando is an oral testosterone product for testo...

4 days ago - Benzinga

Penny Stocks To Watch Today As Buying Drives ADMP, IO, LPCN & Others

A jump in penny stock prices has retail traders cashing out on big gains. The post Penny Stocks To Watch Today As Buying Drives ADMP, IO, LPCN & Others appeared first on Penny Stocks to Buy, Picks, News...

Other symbols:ADMPFAMIIOPROG
4 days ago - PennyStocks

Lipocine And Antares Pharma Enter Into U.S. Licensing Agreement To Commercialize TLANDO®

SALT LAKE CITY, Oct. 18, 2021 /PRNewswire/ -- Under the terms of Agreement Lipocine to receive: Up to $21.0 million in licensing fees, including $11.0 million payable immediately and $10.0 million to be...

5 days ago - PRNewsWire

Lipocine to Present at The H.C. Wainwright 5th Annual NASH Investor Conference

SALT LAKE CITY, Oct. 5, 2021 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the Company will ...

2 weeks ago - PRNewsWire

Lipocine Announces FDA Affirmation Of Class 1 NDA Resubmission For TLANDO®

SALT LAKE CITY, Sept. 28, 2021 /PRNewswire/ -- Lipocine Inc. (Nasdaq: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced the U.S. Food and Dr...

3 weeks ago - PRNewsWire

Lipocine to Present at The Cantor Fitzgerald Virtual Global Healthcare Conference

SALT LAKE CITY, Sept. 20, 2021 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the Company wil...

1 month ago - PRNewsWire

Lipocine to Present at The H.C. Wainwright 23rd Annual Global Investment Conference

SALT LAKE CITY , Sept. 1, 2021 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the Company wil...

1 month ago - PRNewsWire

Top Reddit Penny Stocks to Watch in September 2021

Are these 3 Reddit penny stocks on your watchlist right now? The post Top Reddit Penny Stocks to Watch in September 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks....

Other symbols:CEIGSMG
1 month ago - PennyStocks

Top Penny Stocks Analysts Say To Buy, Targets Up To 200% Right Now

Penny stocks with high marks from analysts right now. The post Top Penny Stocks Analysts Say To Buy, Targets Up To 200% Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | Pen...

Other symbols:SENSVEONXERS
1 month ago - PennyStocks

Lipocine Meets Resolution Regulatory Endpoint In Mid-Stage NASH Trial

Lipocine Inc (NASDAQ: LPCN) has announced topline 36-week results from its Phase 2 proof of concept LiFT study investigating LPCN 1144 in Non-Alcoholic Steatohepatitis (NASH). LPCN 1144 comprises an ora...

1 month ago - Benzinga

Lipocine's LPCN 1144 Met Non-Alcoholic Steatohepatitis ("NASH") Resolution Regulatory Endpoint in Phase 2 LiFT Study

SALT LAKE CITY, Aug. 25, 2021 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced positive topline 36-w...

1 month ago - PRNewsWire

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2021

SALT LAKE CITY, Aug. 5, 2021 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced financial results for ...

2 months ago - PRNewsWire

Lipocine Stock Jumps On Litigation Settlement With Clarus Therapeutics

Lipocine Inc (NASDAQ: LPCN) has entered into a settlement and license agreement with Clarus Therapeutics to resolve claims in the ongoing intellectual property litigation and interference proceeding.  U...

Other symbols:CLAR
3 months ago - Benzinga

Lipocine Announces Settlement With Clarus Therapeutics

SALT LAKE CITY, July 14, 2021 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that it has entered i...

3 months ago - PRNewsWire

Lipocine To Present At The Ladenburg Thalmann Healthcare Conference

SALT LAKE CITY, July 6, 2021 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the Company will ...

3 months ago - PRNewsWire

Lipocine Announces Presentations at The International Liver Congress™ 2021 Digital Event

SALT LAKE CITY, June 23, 2021 /PRNewswire/ -- Lipocine Inc. (Nasdaq: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that clinical data wi...

3 months ago - PRNewsWire

Lipocine To Present At The Raymond James Human Health Innovation Conference

SALT LAKE CITY, June 16, 2021 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the Company will...

4 months ago - PRNewsWire

Lipocine To Start Testing Neuro-Steroid Candidate In Postpartum Depression Patients

The FDA has signed off Lipocine Inc's (NASDAQ: LPCN) Investigational New Drug Application (IND) to initiate a Phase 2 study to evaluate LPCN 1154 for the treatment of postpartum depression (PPD) in adul...

4 months ago - Benzinga

FDA Clears LPCN 1154 IND Application for a Phase 2 Postpartum Depression Study

SALT LAKE CITY, June 14, 2021 /PRNewswire/ -- Lipocine Inc. (Nasdaq: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the U.S. Food an...

4 months ago - PRNewsWire

Lipocine to Present at the Lytham Partners Summer 2021 Investor Conference

SALT LAKE CITY, June 7, 2021 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the Company will ...

4 months ago - PRNewsWire

Clarus Therapeutics Wins Jatenzo Patent Infringement Case Brought By Lipocine

The U.S. District Court for the District of Delaware has granted Clarus Therapeutics' motion for summary judgment against remaining patents in a patent infringement case brought by Lipocine Inc (NASDAQ:...

Other symbols:CLAR
4 months ago - Benzinga

Summary Judgment Ruling in Patent Infringement Lawsuit

SALT LAKE CITY, May 26, 2021 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the United States...

4 months ago - PRNewsWire

Clarus Therapeutics Defeats Lipocine's Patent Infringement Lawsuit On Summary Judgment

NORTHBROOK, Ill., May 25, 2021 /PRNewswire/ -- Today, Federal Circuit Judge William C.

4 months ago - PRNewsWire

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2021

SALT LAKE CITY, May 6, 2021 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced financial results for t...

5 months ago - PRNewsWire

7 Reddit Penny Stocks to Keep Your Eye on for Big Movement

Reddit stocks -- and in particular Reddit penny stocks -- are some of the riskiest shares out there. Yet, investors could make out big with some of the names on this list.

Other symbols:GMEOGISNDLSVRAYVRZOM
6 months ago - InvestorPlace